Haaglanden Medisch Centrum
About Haaglanden Medisch Centrum
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
European Organisation for Research and Treatment of Cancer - EORTC
16
Leiden University Medical Center
13
The Netherlands Cancer Institute
11
Erasmus Medical Center
8
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
7
Radboud University Medical Center
7
UMC Utrecht
4
Borstkanker Onderzoek Groep
3
Ferring Pharmaceuticals
3
Medical Center Haaglanden
3
Amedica Corporation
2
Clinical Trials at Haaglanden Medisch Centrum
During the past decade, Haaglanden Medisch Centrum conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 12 clinical trials were completed, i.e. on
average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 5 clinical trials were completed. i.e. 22.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
1996-08-01
Completed
350
Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed
1996-07-01
Unknown status
4,000
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed
1999-02-01
Terminated
158
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer
2001-02-01
2013-03-01
Completed
4,813
Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients
2003-01-01
Completed
328
Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
2004-03-01
Completed
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Haaglanden Medisch Centrum" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 16 trials, followed by "Leiden University Medical Center" with 13 trials
sponsored, "The Netherlands Cancer Institute" with 11 trials sponsored, "Erasmus Medical Center" with 8 trials sponsored and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)"
with 8 trials sponsored. Other sponsors include 68 different institutions and
companies that sponsored additional 56 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Haaglanden Medisch Centrum"
#1 collaborator was "Medical Center Haaglanden" with 17 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 13 trials as a collaborator, "Erasmus Medical Center" with 12 trials as a collaborator, "Leiden University Medical Center" with 9 trials as a collaborator and "Dutch Cancer Society" with 6 trials as a collaborator. Other collaborators include 236 different institutions and companies that were
collaborators in the rest 180 trials.
Clinical Trials Conditions at Haaglanden Medisch Centrum
According to Clinical.Site data, the most researched conditions in "Haaglanden Medisch Centrum" are
"Breast Cancer" (9 trials), "Brain and Central Nervous System Tumors" (5 trials), "Glioblastoma" (4 trials), "Prostate Cancer" (4 trials) and "Pulmonary Embolism" (4 trials). Many other conditions were trialed in "Haaglanden Medisch Centrum" in a lesser frequency.
Clinical Trials Intervention Types at Haaglanden Medisch Centrum
Most popular intervention types in "Haaglanden Medisch Centrum" are "Drug" (61 trials), "Procedure" (23 trials), "Other" (22 trials), "Device" (15 trials) and "Radiation" (15 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "radiation therapy" (5 trials), "temozolomide" (4 trials), "Bevacizumab" (3 trials) and "Temozolomide" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Haaglanden Medisch Centrum
The vast majority of trials in "Haaglanden Medisch Centrum" are
110 trials for "All" genders, 12 trials for "Female" genders and 6 trials for "Male" genders.
Clinical Trials Status at Haaglanden Medisch Centrum
Currently, there are 46 active trials in "Haaglanden Medisch Centrum".
2 are not yet recruiting,
24 are recruiting,
19 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 57 completed trials in Haaglanden Medisch Centrum,
undefined suspended trials,
and 12 terminated clinical trials to date.
Out of the total trials that were conducted in Haaglanden Medisch Centrum, 3 "Phase 1"
clinical trials were conducted, 26 "Phase 2" clinical
trials and 34 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 11 trials, and there were
also 35 trials that are defined as “Not Applicable".
Departments of Haaglanden Medisch Centrum
Haaglanden Medisch Centrum has several departments that took part in Clinical trials: "MC Haaglanden; Oncologie" - 2 trials
Departments List
Name
City
Trials